as on February 7, 2026 at 7:59 am IST
Day's Low
Day's High
1.54%
Downside
0.71%
Upside
52 Week's Low
52 Week's High
33.90%
Downside
21.58%
Upside
Check Ani Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.8B
EPS (TTM)
7.5654
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.17%
PE Ratio (TTM)
50.28
Industry PE ratio
-1.6902868852459016
PEG Ratio
1.06
EBITDA
142.4M
Revenue (TTM)
826.9M
Profit Margin
4.91%
Return On Equity TTM
8.66%
Track how Ani Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Ani Pharmaceuticals Inc in the last 5 years
Lowest (8.83x)
September 30, 2021
Industry (-1.69x)
February 7, 2026
Today (50.28x)
February 7, 2026
Highest (35.39x)
June 30, 2025
Today’s Price to Earnings Ratio: 50.28x
Compare market cap, revenue, PE, and other key metrics of Ani Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.8B | 166.49% | 50.28 | 4.91% | |
| NA | $14.4B | NA | NA | 0.00% | |
| BUY | $21.6B | NA | 18.08 | 40.65% | |
| BUY | $46.2B | NA | 22.54 | 13.81% | |
| HOLD | $15.2B | -18.52% | -21.95 | -26.13% |
The Ani Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ani Pharmaceuticals Inc investment value today
Current value as on today
₹1,38,470
Returns
₹38,470
(+38.47%)
Returns from Ani Pharmaceuticals Inc Stock
₹35,161 (+35.16%)
Dollar Returns*
₹3,309 (+3.31%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Ani Pharmaceuticals Inc. Average target price of $110.38
Get share price movements and forecasts by analysts on Ani Pharmaceuticals Inc.
What analysts predicted
25.86%UPSIDE
Target Price
$110.38
Current Price
$81.84
Analyzed by
11 Analysts
Target
$110.38
Ani Pharmaceuticals Inc target price $110.38, a slight upside of 25.86% compared to current price of $81.84. According to 11 analysts rating.
Search interest for Ani Pharmaceuticals Inc Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:15% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 05 January
Mon, 09:28 PM
-ANI Pharmaceuticals' EPS estimates for 2025 and 2026 have increased, with shares surging nearly 44% over the past year.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 years, ANIP stock has moved up by 79.0%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 8.54M → 24.13M (in $), with an average increase of 64.6% per quarter
Revenue Rich
![]()
Revenue is up for the last 8 quarters, 131.65M → 227.81M (in $), with an average increase of 7.3% per quarter
Against Peers
![]()
In the last 3 years, Regencell Bioscience Holdings Ltd has given 3349.0% return, outperforming this stock by 3270.0%
Against Peers
![]()
In the last 1 year, Regencell Bioscience Holdings Ltd has given 26082.7% return, outperforming this stock by 26047.5%
| Organisation | Ani Pharmaceuticals Inc |
| Headquarters | 210 Main Street West, Baudette, MN, United States, 56623 |
| Industry | Health Technology |
| CEO | Mr. Nikhil Lalwani |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Stephen P. Carey | Senior VP of Finance & CFO |
Ms. Meredith W. Cook J.D. | Senior VP, General Counsel & Corporate Secretary |
Mr. Christopher K. Mutz | Senior VP & Head of Rare Disease |
Mr. Ori Gutwerg | Senior Vice President of Generics |
Ms. Elizabeth Powell J.D. | Chief Compliance Officer & Head of Legal of Rare Disease |
Mr. Nikhil Lalwani | President, CEO & Director |
Mr. Muthusamy Shanmugam MS R.Ph. | Head of R&D, COO of New Jersey Operations & Director |
Mr. Chad Gassert | Senior Vice President of Corporate Development & Strategy |
Ms. Krista L. Davis | Senior VP & Chief Human Resources Officer |
Dr. Mary Pao M.D., Ph.D. | Chief Medical Officer |
Ani Pharmaceuticals Inc share price today is $81.84 as on at the close of the market. Ani Pharmaceuticals Inc share today touched a day high of $82.42 and a low of $80.58.
Ani Pharmaceuticals Inc share touched a 52 week high of $99.5 on and a 52 week low of $54.1 on . Ani Pharmaceuticals Inc stock price today i.e. is closed at $81.84,which is 17.75% down from its 52 week high and 51.28% up from its 52 week low.
Ani Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Ani Pharmaceuticals Inc (ANIP) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Ani Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ani Pharmaceuticals Inc share’s latest price of $81.84 as on February 7, 2026 at 2:29 am IST, you will get 0.1222 shares of Ani Pharmaceuticals Inc. Learn more about
fractional shares .
Ani Pharmaceuticals Inc stock has given 166.49% share price returns and 23.93% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?